NuCana (NASDAQ:NCNA) Shares Down 6.5% – What’s Next?

NuCana plc (NASDAQ:NCNA)’s share price fell 6.5% during mid-day trading on Thursday . The stock traded as low as $1.14 and last traded at $1.15. 118,431 shares changed hands during trading, an increase of 6% from the average session volume of 111,346 shares. The stock had previously closed at $1.23.

NuCana Price Performance

The firm’s 50-day moving average price is $1.33 and its 200-day moving average price is $2.64. The stock has a market cap of $3.04 million, a P/E ratio of -0.11 and a beta of 0.97.

Institutional Investors Weigh In On NuCana

An institutional investor recently bought a new position in NuCana stock. Glass Jacobson Investment Advisors llc acquired a new stake in shares of NuCana plc (NASDAQ:NCNA) in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm acquired 15,000 shares of the company’s stock, valued at approximately $38,000. Glass Jacobson Investment Advisors llc owned about 0.57% of NuCana as of its most recent SEC filing. Institutional investors and hedge funds own 44.00% of the company’s stock.

About NuCana

NuCana plc, a clinical-stage biopharmaceutical company, engages in the development of medicines to treat patients with cancer. It applies its ProTide technology to transform prescribed chemotherapy agents and nucleoside analogs into medicines. The company, through its technology, is developing ProTides medicines to overcome the limitations of nucleoside analogs and generate much higher concentrations of anti-cancer metabolites in cancer cells.